Pink Lipsticks and Green Thumbs: Mary Kay Inc. Celebrates 60 Years of Sustainable Beauty With Special Tree Planting Event in Lewisville
14.5.2024 19:00:00 EEST | Business Wire | Press release
Mary Kay Inc., a corporate leader in global sustainability, is strengthening its roots in Lewisville. On May 10, the company partnered with the Arbor Day Foundation and Keep Lewisville Beautiful to host a tree planting event at Railroad Park to celebrate Mother Nature and Mother’s Day.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240514127551/en/
Trees planted at Railroad Park directly impact Lewisville communities by providing important ecosystem benefits in the Trinity River watershed. (Photo: Mary Kay Inc.)
“Through partnerships with organizations like the Arbor Day Foundation, Mary Kay is making positive environmental impact in ecosystems where we operate around the world,” said Ryan Rogers, CEO of Mary Kay, Inc., and grandson of Mary Kay Ash. “But change starts in your own backyard. We enjoyed ‘sprucing’ up the community by planting trees that will benefit local families for generations to come.”
Mary Kay volunteers planted 60 native trees along the trails and waterways in Railroad Park, symbolizing the company’s 60th anniversary of enriching the lives of women and their families worldwide and protecting the planet. The park is four miles from Mary Kay’s state-of-the-art Richard R. Rogers (R3) Manufacturing/R&D Center. Trees planted at this location directly impact Lewisville communities by providing much-needed shade in community spaces, enhancing the beautification of recreational areas, and providing important ecosystem benefits in the Trinity River watershed.
"We are thrilled to see Mary Kay contribute to the tree canopy of Lewisville,” said TJ Gilmore, Mayor of Lewisville. “This initiative is not only a breath of fresh air for our city but a testament to the flourishing partnership between our community and a corporation that continuously gives back. Together, we’re making Lewisville a better place to live and work."
Mary Kay’s partnership with the Arbor Day Foundation stretches back more than 16 years—and in that time, the company has helped plant 1.4 million trees around the world. Arbor Day Foundation is the world’s largest membership nonprofit dedicated to planting trees.
“The Arbor Day Foundation is dedicated to helping our local planting partners unlock the transformative power of trees in their community,” said Dan Lambe, Chief Executive of the Arbor Day Foundation. “Trees clean our air, cool our cities, and improve the lives of the people around them. We’re happy to partner again with Mary Kay and Keep Lewisville Beautiful to maximize the impact of the urban canopy and inspire more people to engage with nature in a meaningful way.”
Keep Lewisville Beautiful is a local environmental nonprofit that partners with organizations to plant trees and provide residents opportunities to care for Lewisville’s tree canopy on public lands.
“Tree planting is an investment in our community’s future,” said Amy Wells, Executive Director of Keep Lewisville Beautiful. “These trees will help create shade for families visiting Railroad Park, provide habitat to local wildlife, and will provide a multitude of ecological benefits for our local environment. Keep Lewisville Beautiful is excited to partner with Mary Kay and the Arbor Day Foundation to increase Lewisville’s tree canopy and make a visible difference in our community with Mary Kay volunteers. Their donation to our community and KLB will go a long way towards keeping Lewisville beautiful.”
Following the planting, the Lewisville Parks Department is committed to long-term maintenance and upkeep of the trees with supplemental watering, pruning, and care.
Did you know:
- R3 Manufacturing/R&D Center in Lewisville is named in honor of Mary Kay Inc.’s cofounder and Mary Kay Ash’s son, Richard R. Rogers.
- Built on 26 acres of land, R3 features state-of-the-art R&D laboratories and cutting-edge manufacturing technology.
- 57% of products manufactured at R3 are exported to Mary Kay’s international markets.
- R3 production capacity is up to 1.1 million products per day. The facility boasts 20 product-packaging lines and 21 processing vessels and mixing tanks.
- R3 is LEED Building Design and Construction Silver-Certified facility.
About Mary Kay
Then. Now. Always. One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in more than 35 countries. For 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.
About the Arbor Day Foundation
Founded in 1972, the Arbor Day Foundation is the largest nonprofit membership organization dedicated to planting trees. Together with our partners, we have helped plant more than 500 million trees in neighborhoods, communities, cities, and forests throughout the world. Our vision is to lead toward a world where trees are used to solve issues critical to survival. Through our members, partners and programs, the Arbor Day Foundation inspires people across the globe to plant, nurture and celebrate trees. More information is available at arborday.org.
About Keep Lewisville Beautiful
Keep Lewisville Beautiful (KLB) is a non-profit and award-winning affiliate of Keep America Beautiful and Keep Texas Beautiful. KLB’s mission is to “engage the citizens of Lewisville through service and education to enhance their community environment”. Our vision is to partner with the community to promote environmental quality, making Lewisville the best place to live, work, and play. Annually, KLB volunteers contribute over 10,000 volunteer hours towards litter abatement, environmental education, and beautification programs, and remove 25+ TONS of trash from community green spaces and waterways. Learn more at keeplewisvillebeautiful.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240514127551/en/
Contact information
Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom